Candel Therapeutics Inc (CADL)
$8.33 -3.70% Close Oct 30, 2026 Live
Candel Therapeutics stock today
Candel Therapeutics closed at $8.33 on October 30, 2026, down 3.70% on the day. Over the past year it returned +49.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $610 million.
$5.00$10.00
NovJan 2026MarMayJulSep
| Period | CADL | S&P 500 (SPY) |
|---|---|---|
| 1 month | -20.2% | -0.9% |
| 3 months | -15.6% | +2.1% |
| Year to date | +47.4% | +11.7% |
| 1 year | +49.3% | +12.4% |
| 3 years | +837.0% | +88.5% |
| 5 years | -25.8% | +76.0% |
Key statistics
- Market value
- $610M
- 52-week range
- $4.42 to $13.75
- Next report
- Nov 12, 2026 (estimated)
About Candel Therapeutics
Develops cancer immunotherapy treatments using genetically modified cell therapy.
Sector: Health Care
More on Candel Therapeutics
- Returns: what $1,000 became$1,000 five years ago is $741.76 today
No forecast, no recommendation. This page describes Candel Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.